These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 18091537

  • 1. Pharmacologic cholinesterase inhibition improves survival in experimental sepsis.
    Hofer S, Eisenbach C, Lukic IK, Schneider L, Bode K, Brueckmann M, Mautner S, Wente MN, Encke J, Werner J, Dalpke AH, Stremmel W, Nawroth PP, Martin E, Krammer PH, Bierhaus A, Weigand MA.
    Crit Care Med; 2008 Feb; 36(2):404-8. PubMed ID: 18091537
    [Abstract] [Full Text] [Related]

  • 2. Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis.
    Sheehan M, Wong HR, Hake PW, Zingarelli B.
    Crit Care Med; 2003 Sep; 31(9):2263-70. PubMed ID: 14501955
    [Abstract] [Full Text] [Related]

  • 3. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.
    Pavlov VA, Ochani M, Yang LH, Gallowitsch-Puerta M, Ochani K, Lin X, Levi J, Parrish WR, Rosas-Ballina M, Czura CJ, Larosa GJ, Miller EJ, Tracey KJ, Al-Abed Y.
    Crit Care Med; 2007 Apr; 35(4):1139-44. PubMed ID: 17334244
    [Abstract] [Full Text] [Related]

  • 4. Role of nuclear factor-kappaB-dependent induction of cytokines in the regulation of vasopressin V1A-receptors during cecal ligation and puncture-induced circulatory failure.
    Schmidt C, Höcherl K, Kurt B, Bucher M.
    Crit Care Med; 2008 Aug; 36(8):2363-72. PubMed ID: 18596633
    [Abstract] [Full Text] [Related]

  • 5. Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway.
    Fodale V, Santamaria LB.
    Crit Care Med; 2008 Feb; 36(2):622-3. PubMed ID: 18216614
    [No Abstract] [Full Text] [Related]

  • 6. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis.
    Huston JM, Gallowitsch-Puerta M, Ochani M, Ochani K, Yuan R, Rosas-Ballina M, Ashok M, Goldstein RS, Chavan S, Pavlov VA, Metz CN, Yang H, Czura CJ, Wang H, Tracey KJ.
    Crit Care Med; 2007 Dec; 35(12):2762-8. PubMed ID: 17901837
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of NF-kappaB activity prevents downregulation of alpha1-adrenergic receptors and circulatory failure during CLP-induced sepsis.
    Schmidt C, Kurt B, Höcherl K, Bucher M.
    Shock; 2009 Sep; 32(3):239-46. PubMed ID: 19106815
    [Abstract] [Full Text] [Related]

  • 8. Inflammatory status in sepsis alters efficacy of interleukin-18 binding protein therapy.
    Remick DG, Bolgos GE, Siddiqui J.
    Crit Care Med; 2003 Aug; 31(8):2096-101. PubMed ID: 12973165
    [Abstract] [Full Text] [Related]

  • 9. Effects of a peripheral cholinesterase inhibitor on cytokine production and autonomic nervous activity in a rat model of sepsis.
    Setoguchi D, Yatsuki H, Sadahiro T, Nakamura M, Hirayama Y, Watanabe E, Tateishi Y, Oda S.
    Cytokine; 2012 Feb; 57(2):238-44. PubMed ID: 22138106
    [Abstract] [Full Text] [Related]

  • 10. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis.
    Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, Tracey KJ, Ulloa L.
    Nat Med; 2004 Nov; 10(11):1216-21. PubMed ID: 15502843
    [Abstract] [Full Text] [Related]

  • 11. Low-molecular-weight polyethylene glycol improves survival in experimental sepsis.
    Ackland GL, Gutierrez Del Arroyo A, Yao ST, Stephens RC, Dyson A, Klein NJ, Singer M, Gourine AV.
    Crit Care Med; 2010 Feb; 38(2):629-36. PubMed ID: 20009757
    [Abstract] [Full Text] [Related]

  • 12. Nuclear factor-kappaB decoy oligodeoxynucleotides ameliorate impaired glucose tolerance and insulin resistance in mice with cecal ligation and puncture-induced sepsis.
    Matsuda N, Yamamoto S, Yokoo H, Tobe K, Hattori Y.
    Crit Care Med; 2009 Oct; 37(10):2791-9. PubMed ID: 19707125
    [Abstract] [Full Text] [Related]

  • 13. The neuronal strategy for inflammation.
    Ulloa L, Wang P.
    Novartis Found Symp; 2007 Oct; 280():223-33; discussion 233-7. PubMed ID: 17380797
    [Abstract] [Full Text] [Related]

  • 14. Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis.
    Tsao PN, Chan FT, Wei SC, Hsieh WS, Chou HC, Su YN, Chen CY, Hsu WM, Hsieh FJ, Hsu SM.
    Crit Care Med; 2007 Aug; 35(8):1955-60. PubMed ID: 17568329
    [Abstract] [Full Text] [Related]

  • 15. In Vivo Effects of Neostigmine and Physostigmine on Neutrophil Functions and Evaluation of Acetylcholinesterase and Butyrylcholinesterase as Inflammatory Markers during Experimental Sepsis in Rats.
    Bitzinger DI, Gruber M, Tümmler S, Malsy M, Seyfried T, Weber F, Redel A, Graf BM, Zausig YA.
    Mediators Inflamm; 2019 Aug; 2019():8274903. PubMed ID: 30804708
    [Abstract] [Full Text] [Related]

  • 16. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis.
    van Westerloo DJ, Giebelen IA, Florquin S, Daalhuisen J, Bruno MJ, de Vos AF, Tracey KJ, van der Poll T.
    J Infect Dis; 2005 Jun 15; 191(12):2138-48. PubMed ID: 15898001
    [Abstract] [Full Text] [Related]

  • 17. Plasma gelsolin is a marker and therapeutic agent in animal sepsis.
    Lee PS, Waxman AB, Cotich KL, Chung SW, Perrella MA, Stossel TP.
    Crit Care Med; 2007 Mar 15; 35(3):849-55. PubMed ID: 17205019
    [Abstract] [Full Text] [Related]

  • 18. Thioredoxin in human and experimental sepsis.
    Hofer S, Rosenhagen C, Nakamura H, Yodoi J, Bopp C, Zimmermann JB, Goebel M, Schemmer P, Hoffmann K, Schulze-Osthoff K, Breitkreutz R, Weigand MA.
    Crit Care Med; 2009 Jul 15; 37(7):2155-9. PubMed ID: 19487947
    [Abstract] [Full Text] [Related]

  • 19. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro.
    Haddad JJ.
    Mol Immunol; 2009 Dec 15; 47(2-3):205-14. PubMed ID: 19850345
    [Abstract] [Full Text] [Related]

  • 20. Nicotinic acetylcholine receptor activation mediates nicotine-induced enhancement of experimental periodontitis.
    Breivik T, Gundersen Y, Gjermo P, von Hörsten S, Opstad PK.
    J Periodontal Res; 2009 Feb 15; 44(1):110-6. PubMed ID: 18973546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.